Philips Sells Xiver Chipmaking Subsidiary, Report Reveals

Philips, the global healthcare technology company, has sold its small chipmaking subsidiary, Xiver, according to a report by the Telegraaf newspaper, citing the company’s CEO. The subsidiary was acquired by a consortium led by Orange Mills Ventures, the investment firm of Dutch businessman Cees Meeuwis. The financial details of the transaction were not disclosed.

Xiver, which specializes in manufacturing micro-electromechanical systems (MEMS)—a combination of mechanical and electronic components on a silicon chip—had been struggling financially and was described as a loss-making business. The subsidiary employed around 100 people. CEO John van Soerland, who retired from VDL last year, confirmed that Xiver supplies to major industry players, including ASML and the French defense firm Lynred.

Philips, which sold most of its semiconductor-related businesses, including ASML, several years ago, has since focused its efforts primarily on the healthcare sector. Xiver’s sale marks another step in the company’s strategy to streamline its operations, continuing its shift away from semiconductor manufacturing. Philips’ former semiconductor businesses, which include NXP and Nexperia, have now been spun off into separate entities.